Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
Aes Simões, D. M. Pereira, S. E. Gomes, H. Brito, T. Carvalho, A. French, R. E. Castro, C. J. Steer, S. N. Thibodeau, C. M.P. Rodrigues, P. M. Borralho
Dive into the research topics of 'Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation'. Together they form a unique fingerprint.